Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(13 sites)

United States

Clinical Research Site, Chino, California

Clinical Research Site, Redlands, California

Clinical Research Site, Walnut Creek, California

Clinical Research Site, Jacksonville, Florida

Clinical Research Site, Miami, Florida

Clinical Research Site, Cherry Hill, New Jersey

Clinical Research Site, Toms River, New Jersey

Clinical Research Site, Brooklyn, New York

Clinical Research Site, The Bronx, New York

Clinical Research Site, Cincinnati, Ohio

Clinical Research Site, Portland, Oregon

Clinical Research Site, Memphis, Tennessee

Clinical Research Site, Dallas, Texas